Portfolio company
Rebus Biosystems, Inc.
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This life science technology company develops automated spatial omics platforms for researchers and pharmaceutical groups to analyse gene expression within tissue samples.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
RareCyte
RareCyte develops multiplexed imaging instruments and consumables for spatial biology and liquid biopsy, serving pharmaceutical companies and academic researchers in life sciences.
10X Genomics
This company develops instruments, consumables and software for single-cell and spatial biology research, serving academic institutions and biopharmaceutical firms.
Cubase Bio
This company develops optics-free DNA microscopy kits for three-dimensional spatial transcriptomics to support drug discovery and disease research for pharmaceutical and academic organisations.
lunaphore
This company develops spatial biology platforms and automated tissue analysis systems for laboratories, hospitals and researchers to advance cancer diagnostics and drug development.
AKYA
This company provides spatial phenotyping solutions to researchers and clinicians for visualizing and quantifying protein and RNA expression in tissue sections.
BigOmics Analytics
This company develops self-service software platforms for bioinformaticians and biologists to analyse and visualise transcriptomics and proteomics data within life science organisations.
Micrographia Bio
This company develops AI-driven microscopy and spatial proteomics platforms to help drug developers and researchers visualise molecular interactions and identify therapeutic targets.
Enable Medicine
Enable Medicine provides a cloud-based spatial biology platform for life science researchers and pharmaceutical companies to analyse cellular data and discover new drug targets.
